chimeric antigen receptor

T cells have long held the title of the ideal immune cells for CAR therapy, but recent discoveries are opening new possibilities for other immune cells.

Single amino acid changes in healthy hematopoietic stem cells may lead to safer treatments for acute myeloid leukemia.

Natural killer cells offer safe and effective cancer treatment, but to succeed in the clinic, they need a bit of an energy boost.

Chimeric antigen receptor engineering is now possible for immune cells other than T cells, including macrophages and invariant natural killer T cells.

A team of industry and academic researchers developed a new way to engineer the immune system, leading to the first clinical trial using genetically modified macrophages.

Learn how scientists leverage the power of natural killer cells to fight cancer.